Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.

Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Yang K, Zhou J, Shen R, Zhang X, Shao Y.

Viral Immunol. 2012 Dec;25(6):477-84. doi: 10.1089/vim.2012.0014. Epub 2012 Nov 21.

2.

A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.

Meng Q, Lin Y, Ma J, Ma Y, Zhao L, Li S, Liang H, Zhou J, Shen R, Zhang X, Shao Y.

Arch Virol. 2011 Aug;156(8):1455-62. doi: 10.1007/s00705-011-0992-1. Epub 2011 Apr 17.

PMID:
21499906
3.

Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC.

J Virol. 2008 Apr;82(8):4052-63. doi: 10.1128/JVI.02028-07. Epub 2008 Jan 30.

4.

Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.

Mealey RH, Leib SR, Littke MH, Wagner B, Horohov DW, McGuire TC.

Vaccine. 2009 Apr 21;27(18):2453-68. doi: 10.1016/j.vaccine.2009.02.048. Epub 2009 Feb 24.

5.

An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.

Lin YZ, Shen RX, Zhu ZY, Deng XL, Cao XZ, Wang XF, Ma J, Jiang CG, Zhao LP, Lv XL, Shao YM, Zhou JH.

Antiviral Res. 2011 Nov;92(2):292-304. doi: 10.1016/j.antiviral.2011.08.016. Epub 2011 Aug 25.

PMID:
21893100
6.

[The difference in specific humoral immune responses induced with the attenuated equine infectious anemia vaccine strain and virulent strain.].

Zhu ZY, Lin YZ, Wang YH, Zhao LP, Zhu YM, Zhou JH.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Dec;25(12):1079-83. Chinese.

PMID:
19961789
7.
8.

Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Craigo JK, Ezzelarab C, Cook SJ, Liu C, Horohov D, Issel CJ, Montelaro RC.

PLoS Pathog. 2015 Jan 8;11(1):e1004610. doi: 10.1371/journal.ppat.1004610. eCollection 2015 Jan.

9.
10.

Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.

Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC.

J Gen Virol. 2007 Apr;88(Pt 4):1324-36.

PMID:
17374779
11.

Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.

Craigo JK, Li F, Steckbeck JD, Durkin S, Howe L, Cook SJ, Issel C, Montelaro RC.

J Virol. 2005 Mar;79(5):2666-77.

12.
13.

C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.

Jiang CG, Gao X, Ma J, Lin YZ, Wang XF, Zhao LP, Hua YP, Liu D, Zhou JH.

Virus Res. 2011 Jun;158(1-2):235-45. doi: 10.1016/j.virusres.2011.04.007. Epub 2011 Apr 22.

PMID:
21539871
14.

Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC.

Vaccine. 2007 Jan 15;25(5):834-45. Epub 2006 Sep 22.

15.
16.

Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression.

Zhang X, Wang Y, Liang H, Wei L, Xiang W, Shen R, Shao Y.

J Gen Virol. 2007 Mar;88(Pt 3):998-1004.

PMID:
17325374
17.

Envelope determinants of equine lentiviral vaccine protection.

Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC.

PLoS One. 2013 Jun 13;8(6):e66093. doi: 10.1371/journal.pone.0066093. Print 2013.

18.

Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.

Issel CJ, Horohov DW, Lea DF, Adams WV Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC.

J Virol. 1992 Jun;66(6):3398-408.

19.

Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.

Liu L, Wan Y, Wu L, Sun J, Li H, Li H, Ma L, Shao Y.

Retrovirology. 2010 Sep 1;7:71. doi: 10.1186/1742-4690-7-71.

20.

[Induction of EIAV-specific cellular immune response by attenuated EIAV vaccine].

Zhang XY, Li HM, Liang H, Shen T, Ma Y, Xiang WH, Shen RX, Shao YM.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jan;22(1):115-8. Chinese.

PMID:
16388761
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk